These hypotheses were tested by Robinson and co-workers [140], who investigated 766 autopsied samples representing a broad spectrum of neurodegenerative diseases, related to the aggregation of tau, Aβ, α-Syn, and TDP-43 as well as a group with minimal pathology, where no neuropathological disease was clinically diagnosed. Here, MAPT is linked to neurodegenerative disease.